Novel sex-biased outcomes in neuroblastoma are associated with distinct gene expression and chromosomal loss patterns.
V. Patel, M. Raleigh, L.-R. E. Benhamou, X. Shen, E. C. Espinosa, N. R. Badi, D. A. Sheeter, J. T. Powers
The paper identifies sex-biased outcomes in neuroblastoma, showing female patients with MYCN non-amplified high-risk disease have worse survival than males, linked to H19/DLK1 expression and chromosome 11q retention.
bioRxiv · Jun 14, 2024 · PreprintCancer Biology